Biowaiver monographs for immediate release solid oral dosage forms: Cimetidine
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing cimetidine are reviewed. According to the current Biopharmaceutics Classification System (BCS), cimetidine would be assigned...
Saved in:
Main Authors: | E. Jantratid, S. Prakongpan, J. B. Dressman, G. L. Amidon, H. E. Junginger, K. K. Midha, D. M. Barends |
---|---|
其他作者: | Mahidol University |
格式: | Review |
出版: |
2018
|
主題: | |
在線閱讀: | https://repository.li.mahidol.ac.th/handle/123456789/23913 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Biowaiver monographs for immediate release solid oral dosage forms: Lamivudine
由: S. Strauch, et al.
出版: (2018) -
Biowaiver monographs for immediate release solid oral dosage forms: Mefloquine hydrochloride
由: S. Strauch, et al.
出版: (2018) -
Feasibility of biowaiver extension to Biopharmaceutics Classification System Class III drug products: Cimetidine
由: Ekarat Jantratid, et al.
出版: (2018) -
The biowaiver procedure: Its application to antituberculosis products in the WHO prequalification programme
由: Stefanie Strauch, et al.
出版: (2018) -
Convenient and rapid determination of cimetidine in human plasma using perchloric acid-mediated plasma protein precipitation and high-performance liquid chromatography
由: Ekarat Jantratid, et al.
出版: (2018)